140 related articles for article (PubMed ID: 30449258)
1. Pharmacoinformatics-based identification of chemically active molecules against Ebola virus.
Islam MA; Pillay TS
J Biomol Struct Dyn; 2019 Sep; 37(15):4104-4119. PubMed ID: 30449258
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
3. Screening of inhibitors as potential remedial against Ebolavirus infection: pharmacophore-based approach.
Sankar M; K L; Jeyachandran S; Pandi B
J Biomol Struct Dyn; 2021 Feb; 39(2):395-408. PubMed ID: 31928158
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics and combined docking studies for the identification of Zaire ebola virus inhibitors.
Sulaiman KO; Kolapo TU; Onawole AT; Islam MA; Adegoke RO; Badmus SO
J Biomol Struct Dyn; 2019 Aug; 37(12):3029-3040. PubMed ID: 30058446
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel VP35 inhibitors: Virtual screening driven new scaffolds.
Ren JX; Zhang RT; Zhang H; Cao XS; Liu LK; Xie Y
Biomed Pharmacother; 2016 Dec; 84():199-207. PubMed ID: 27657828
[TBL] [Abstract][Full Text] [Related]
8. β-secretase inhibitors for Alzheimer's disease: identification using pharmacoinformatics.
Islam MA; Pillay TS
J Biomol Struct Dyn; 2019 Feb; 37(2):503-522. PubMed ID: 29388503
[TBL] [Abstract][Full Text] [Related]
9. Molecular modelling studies on adamantane-based Ebola virus GP-1 inhibitors using docking, pharmacophore and 3D-QSAR.
Mali SN; Chaudhari HK
SAR QSAR Environ Res; 2019 Mar; 30(3):161-180. PubMed ID: 30786763
[TBL] [Abstract][Full Text] [Related]
10. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
[TBL] [Abstract][Full Text] [Related]
11. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J
J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817
[TBL] [Abstract][Full Text] [Related]
12. Ligand and structure-based computational designing of multi-target molecules directing FFAR-1, FFAR-4 and PPAR-G as modulators of insulin receptor activity.
Mishra S; Rajput MS; Rathore D; Dahima R
J Biomol Struct Dyn; 2022 Sep; 40(15):6974-6988. PubMed ID: 33648410
[TBL] [Abstract][Full Text] [Related]
13. Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.
Mirza MU; Ikram N
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792169
[TBL] [Abstract][Full Text] [Related]
14. Herbal Lead as Ideal Bioactive Compounds Against Probable Drug Targets of Ebola Virus in Comparison with Known Chemical Analogue: A Computational Drug Discovery Perspective.
Setlur AS; Naik SY; Skariyachan S
Interdiscip Sci; 2017 Jun; 9(2):254-277. PubMed ID: 26857866
[TBL] [Abstract][Full Text] [Related]
15. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
17. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
Qiu Y; Zhou L; Hu Y; Bao Y
J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
Choubey SK; Jeyaraman J
J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
[TBL] [Abstract][Full Text] [Related]
20. Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola.
Nasution MAF; Toepak EP; Alkaff AH; Tambunan USF
BMC Bioinformatics; 2018 Nov; 19(Suppl 14):419. PubMed ID: 30453886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
